Alzheimer's disease is characterized by the accumulation of neurotoxic amyloidogenic peptide A␤, degeneration of the cholinergic innervation to the hippocampus (the septohippocampal pathway), and progressive impairment of cognitive function, particularly memory. A␤ is a ligand for the p75 neurotrophin receptor (p75 NTR ), which is best known for mediating neuronal death and has been consistently linked to the pathology of Alzheimer's disease. Here we examined whether p75 NTR is required for A␤-mediated effects. Treatment of wild-type but not p75 NTR -deficient embryonic mouse hippocampal neurons with human A␤ 1-42 peptide induced significant cell death. Furthermore, injection of A␤ 1-42 into the hippocampus of adult mice resulted in significant degeneration of wild-type but not p75 NTR -deficient cholinergic basal forebrain neurons, indicating that the latter are resistant to A␤-induced toxicity. We also found that neuronal death correlated with A␤ 1-42 peptide-stimulated accumulation of the death-inducing p75 NTR C-terminal fragment generated by extracellular metalloprotease cleavage of full-length p75 NTR . Although neuronal death was prevented in the presence of the metalloprotease inhibitor TAPI-2 (tumor necrosis factor-␣ protease inhibitor-2), A␤ 1-42 -induced accumulation of the C-terminal fragment resulted from inhibition of ␥-secretase activity. These results provide a novel mechanism to explain the early and characteristic loss of cholinergic neurons in the septohippocampal pathway that occurs in Alzheimer's disease.
Introduction
Alzheimer's disease is a neurodegenerative disorder characterized by senile plaque pathology, neurofibrillary tangles, and neuronal death, with resultant impairment of memory and cognitive function. Amyloid ␤ protein (A␤), the major component of senile plaques, is a 39 -43 aa peptide produced by cleavage of the amyloid protein precursor. According to the "amyloid hypothesis," accumulation of soluble A␤ in the brain is the primary cause of the pathogenesis of Alzheimer's disease (Hardy and Selkoe, 2002) , but with A␤ oligomers rather than amyloid deposits being the cause of the neurotoxicity associated with this condition (Dahlgren et al., 2002; Klein et al., 2004; Gandy, 2005) .
Loss of basal forebrain cholinergic neurons that innervate the hippocampus and neocortex is an early and key feature of Alzheimer's disease (Yan and Feng, 2004; Wu et al., 2005) . These cholinergic neurons express high levels of the p75 neurotrophin receptor (p75 NTR ), which mediates cell death in a wide range of neuronal subtypes (Dechant and Barde, 2002) . p75 NTR expression has been consistently linked to changes occurring in Alzheimer's disease (Schliebs, 2005) , including the death of basal forebrain neurons (Yeo et al., 1997; Volosin et al., 2006) . Like the amyloid protein precursor (APP), the extracellular domain of p75 NTR is cleaved by a metalloprotease, generating a transmembrane-linked C-terminal fragment. This is then cleaved by ␥-secretase, liberating a soluble intracellular domain (Jung et al., 2003) . Ligand binding can initiate this process, and both fragments of p75 NTR have been shown to mediate death signaling (Kenchappa et al., 2006; Podlesniy et al., 2006; Coulson et al., 2008; Underwood et al., 2008) .
The classic p75 NTR ligands are the neurotrophins nerve growth factor, brain-derived neurotrophic factor, and neurotrophin-3. These are secreted as immature forms (proneurotrophins), which are sometimes cleaved to produce the mature forms (Fahnestock et al., 2001) . It has previously been proposed that increased levels of proneurotrophins, such as occur in Alzheimer's disease, may underlie cholinergic neuronal degeneration (Fahnestock et al., 2001; Volosin et al., 2006) . However, it is also possible that A␤ could be directly responsible for activating p75 NTR -mediated cell death in Alzheimer's disease, given that it is a ligand for the receptor (Yaar et al., 1997) 
Materials and Methods
A␤ preparation. Human A␤ 1-42 peptide and control human A␤ 1-16 peptide were purchased from Dr. J Elliot (Yale University, New Haven, CT). Unless otherwise stated, peptides were dissolved in sterile water at a concentration of 200 M and stored at 4°C (Yaar et al., 1997) . Peptide solutions were incubated at 37°C for 1 h before experimental use and were found to occur in a predominantly oligomeric form (supplemental Fig. 1 A, available at www.jneurosci.org as supplemental material), which was more toxic to hippocampal neurons than the fibrillar form (supplemental Fig. 1 NTR -knock-out (Lee et al., 1992 ) C57BL/6 mice. They were then dissociated in 0.05% trypsin (Invitrogen, Melbourne, Australia), plated on 35 mm dishes coated with poly-L-lysine (0.1 mg/ml; Sigma-Aldrich, Sydney, Australia), and cultured for 24 h in a 1:1 mixture of minimal essential medium (Invitrogen) and Ham's F-12 medium (Invitrogen) supplemented with NeuroCult (StemCell Technologies, Vancouver, British Columbia, Canada) . Approximately 95% of cells within the cultures were p75 NTR -positive neurons (supplemental Fig. 2 A, B, available at www.jneurosci.org as supplemental material). Live cells within a defined grid were then counted (t ϭ 0) under phase microscopy (n ϭ 4 wells per condition per experiment). A␤ peptides or inhibitors were dissolved in fresh culture medium and applied after the t ϭ 0 cell count. The final concentrations were 5 or 20 M A␤ peptides, a 1:100 dilution of anti-extracellular p75 NTR antibody (Ab1554; Millipore Bioscience Research Reagents, Melbourne, Australia), 200 nM compound E ␥-secretase inhibitor (Calbiochem, Melbourne, Australia), and 20 M tumor necrosis factor-␣ protease inhibitor-2 (TAPI-2; Peptides International, Louisville, KY). In some experiments using the metalloprotease inhibitor TAPI-2, a second 20 M dose of TAPI-2 was added into the culture medium at t ϭ 6 h. Twenty-four hours after A␤ treatment, the viability of the same neurons was again assessed, and the percentage survival was determined.
p75 NTR cleavage in hippocampal neurons. To determine the effect of A␤ treatment on the proteolysis of p75 NTR , hippocampal neurons plated in six-well plates for 24 h were pretreated with 5 M ␤-clasto-lactacystin (Calbiochem) proteasome inhibitor for 90 min, after which they were treated for 3 h with a mixture of 20 M A␤ 1-42 , 200 nM compound E, and/or 200 nM phorbol 12-myristate 13-acetate (PMA; Sigma-Aldrich). Cell lysates were separated using 4 -20% Tris-glycine gradient gels (Invitrogen) and Western blotted using rabbit anti-human p75 NTR intracellular domain (1:2000; Promega, Sydney, Australia). Immunoreactive bands were quantified using ImageJ software. The amount of C-terminal fragment was determined as a ratio to full-length p75 NTR within each lane.
DNA constructs. Full-length p75 NTR rat cDNA was as previously described (Coulson et al., 2000) . A p75 NTR C-terminal fragment mimic that is constitutively cleaved (⌬E14) was made as described by Jung et al. (2003) . The C99 APP plasmid contained Gal4 DNA binding and VP16 transactivation domains fused to the carboxyl end (C99-Gal4) (Sernee et al., 2003) . A ⌬E14 construct was similarly modified (⌬E14-Gal4) using standard methods. The luciferase reporter gene construct (pUAS) and the constitutively active plasmid (pCMV-Gal) were as previously described (Karlstrom et al., 2002) . p75 NTR cleavage in HEK293 cells. The effect of A␤ treatment on the proteolysis of p75 NTR was determined using human embryonic kidney 293 (HEK293) cells grown in RPMI (Roswell Park Memorial Institute) medium and 10% fetal bovine serum. Cells were plated at 7.5 ϫ 10 4 in 24-well plates and transiently transfected with 1 g of plasmid DNA using Fugene6 (Roche, Basel, Switzerland) per well. A␤ 1-42 (16 M) was added to the cells either 48 (overnight treatment) or 52 (3 h treatment) hours after transfection. Before cell harvest, cells were treated with ␤-clasto-lactacystin, compound E, and PMA as described above. Cell lysates were Western blotted and the results were analyzed as described above.
Luciferase cleavage assay. For luciferase experiments, HEK293 cells were plated and transfected with the pUAS plasmid together with the ⌬E14-Gal4, C99-Gal4, or pCMV-Gal plasmid. The cells were then incubated overnight and/or for 3 h in A␤ or compound E, before being harvested in reporter lysis buffer. Lysis supernatant (20 l) was assessed using the Luciferase Activity System according to the manufacturer's instructions (Promega). In each experiment, three to six replica lysates were analyzed. The total protein in each lysate was also quantified using a BCA assay kit (Pierce, Rockford, IL).
A␤ injections. Eight-week-old wild-type and p75 NTR knock-out C57BL/6 mice were anesthetized with 8 mg/kg xylazine and 80 mg/kg ketamine by intraperitoneal injection and mounted in a stereotaxic frame. The skull was exposed and a burr hole made at stereotaxic coordinates measured from bregma (anteroposterior, Ϫ2.0 mm; mediolateral, Ϫ1.3 mm; ventral, Ϫ2.2 mm), through which 0.5 l of saline or 100 g/ml A␤ was injected into the CA1 region of the hippocampus at a rate of 0.5 l/min. The needle was kept in this configuration for 2 min to prevent reflux of the injected material along the injection track. In cases in which mice were administered bilateral injections, they received A␤ 1-16 ipsilaterally and saline contralaterally, or A␤ 1-42 ipsilaterally and A␤ 1-16 contralaterally. Animals were perfused with 4% paraformaldehyde 14 d after injection.
Histology. To determine cell survival of cholinergic basal forebrain neurons, the rostral half of each brain between Ϫ1.4 and Ϫ0.5 mm from bregma (the medial septum and diagonal band of Broca) was cut by vibratome into 15 60-m-thick serial coronal sections. Floating sections were stained with a rabbit anti-choline acetyltransferase (ChAT) polyclonal antibody (1:500; Ab143; Millipore Bioscience Research Reagents), and all ChAT-positive neurons in the area of interest were counted based on the method of Greferath et al. (2000) .
Statistical analysis. The data were analyzed by ANOVA using the Newman-Keuls multiple-comparison test. All results are expressed as mean Ϯ SD.
Results

To investigate whether p75
NTR is required for A␤-induced neuronal death, we first established an in vitro model of toxicity in E16 embryonic hippocampal neuron cultures, which have been found to be independently sensitive to both A␤- (Ueda et al., 1994) and p75 NTR -mediated death (Troy et al., 2002) . We found that 24 h after plating in serum-free medium, neurons were sensitive to an overnight incubation with oligomeric 5 or 20 M A␤ 1-42 but not 20 M A␤ 1-16 or vehicle (Fig. 1 A) .
To test whether p75 NTR was required for the observed neuronal death, the effect of A␤ 1-42 on hippocampal neurons isolated from p75 NTR -deficient mice was determined. In contrast to the results obtained with wild-type neurons, A␤ 1-42 failed to induce the death of p75 NTR -deficient neurons even at 20 M (Fig. 1 A) , indicating that p75 NTR is required for A␤-induced death in vitro. An extracellular antibody to p75 NTR also significantly inhibited A␤ 1-42 -induced hippocampal cell death (Fig. 1 B) .
Given that A␤ is a known ligand for p75 NTR , the effect of A␤ 1-42 on p75 NTR proteolytic processing was next examined. Hippocampal neurons were treated for 3 h with 20 M A␤ 1-42 before analysis by Western blot (Fig. 2 A) . This analysis revealed that neurons exposed to A␤ 1-42 contained significantly more p75 NTR C-terminal fragment than control neurons (Fig. 2 B) , the amount being equivalent to that found when intracellular cleavage was blocked with compound E, a ␥-secretase inhibitor, for the same period of time (Fig. 2 A, B ). An intracellular domain fragment of p75 NTR was not apparent. To determine whether cleavage was required for death signaling, extracellular cleavage was blocked with the metalloprotease inhibitor TAPI-2 (Jung et al., 2003) . This completely inhibited A␤ 1-42 -but not staurosporineinduced neuronal death in a dose-dependent manner (Fig.  2C,D) . In contrast, compound E treatment resulted in a slight increase in A␤-induced death (Fig. 2 E) .
To further examine the effect of A␤ on p75 NTR cleavage, p75 NTR was expressed in HEK293 fibroblast cells. Overnight treatment [but not 3 h treatment (supplemental Fig. 3A , available at www.jneurosci.org as supplemental material)] with A␤ 1-42 resulted in a significant increase in the amount of C-terminal fragment (Fig. 3 A, B) . However, in contrast to phorbol ester (PMA) treatment, there was less generation of the intracellular domain fragment of p75 NTR (Fig. 3C) . Interestingly, when the two treatments were combined, the resulting cleavage appeared cumulative ( Fig. 3A-C; supplemental Fig. 3A , available at www. jneurosci.org as supplemental material), suggesting that their actions were independent, possibly acting on different subcellular pools of p75 NTR . Because increased amounts of C-terminal fragment could result from either increased metalloprotease activity or reduced ␥-secretase activity, and coexpression of an APP ␥-secretase substrate (C99) together with p75 NTR also significantly promoted accumulation of the p75 NTR C-terminal fragment (supplemental Fig. 2 A, available at www.jneurosci.org as supplemental material) (Urra et al., 2007) , we hypothesized that A␤ 1-42 might be competing with p75
NTR for ␥-secretase activity, rather than, or as well as, acting as a p75 NTR ligand to promote extracellular cleavage.
Therefore, we next tested whether A␤ could alter the rate of intracellular cleavage of a p75 NTR protein lacking the extracellular domain (⌬E14) (Jung et al., 2003) . Although not as efficient as treatment with a ␥-secretase inhibitor, cells treated overnight with A␤ had discernibly less intracellular domain fragment than untreated cells (Fig. 3D) . To quantify this, we used a ⌬E14 construct and a similar APP construct (C99-Gal4) in which the Gal4 transactivation domains had been fused to their carboxyl ends (Sernee et al., 2003) . Only when released after ␥-secretase cleavage of the C-terminal protein can the activator domain promote transcription of a cotransfected luciferase reporter gene (pUAS), the activity of which can be fluorometrically quantified in cell lysates (Karlstrom et al., 2002) . Using this method, we found that overnight treatment of ⌬E14-Gal4-expressing HEK293 cells with A␤ 1-42 significantly inhibited the resultant luciferase activity, whereas the control peptide A␤ 1-16 had no significant effect (Fig.  3E) . Importantly, our results using the C99-Gal4 construct also showed a significant effect after an overnight A␤ treatment regimen, which was similar to the level of inhibition seen when the ␥-secretase inhibitor was applied overnight (Fig. 3F ) . Given that the assay is based on a transcriptional readout, it was not surprising that no significant effects were seen after the 3 h treatments. These results indicate that A␤ 1-42 can generically inhibit ␥-secretase activity, and suggest that the increased level of p75 NTR C-terminal fragment in cells treated with A␤ is, at least partially, caused by this effect.
Loss of basal forebrain cholinergic neurons through degeneration of the septohippocampal pathway is a major feature of Alzheimer's disease. To determine whether A␤ 1-42 -induced toxicity in cholinergic neurons innervating the hippocampus was mediated by p75 NTR , A␤ 1-42 or A␤ 1-16 peptide solution was injected into the hippocampus of wild-type and p75 NTRdeficient mice. Fourteen days after the injection, the septohippocampal pathway was examined histologically. Regardless of the injected solution or mouse genotype, the needle track through the CA1 region of the hippocampus was identified, revealing no obvious difference in the amount of tissue damage in this area (supplemental Fig. 4 , available at www.jneurosci.org as supplemental material). In contrast, the number of ChAT-positive neurons in the medial septum and diagonal band of Broca after A␤ 1-42 exposure was affected by genotype. First, the number of ChATpositive neurons in the diagonal band of Broca of the ipsilateral hemisphere of wildtype mice injected with saline (n ϭ 4, data not shown) or A␤ 1-16 was not significantly different from that found in uninjected hemispheres (Fig. 4 A) . However, the number of ChAT-positive neurons in the same region of mice injected with A␤ 1-42 was significantly reduced compared with that of uninjected, saline-injected, or A␤ 1-16 -injected animals (Fig. 4 A, B) . Most importantly, however, the number of ChATpositive neurons in p75 NTR -deficient mice after injection with A␤ 1-16 or A␤ 1-42 did not differ significantly, and was similar to that found in uninjected wild-type mice (Fig. 4 A, C) . These results demonstrate that p75 NTR is also required for A␤ 1-42 -mediated neuronal toxicity in vivo.
Discussion
Here we provide evidence that p75 NTR is required for oligomeric A␤ 1-42 -mediated neuronal death in vitro and in vivo, further strengthening the case that p75
NTR plays a role in the etiology of Alzheimer's disease. We found that embryonic hippocampal neurons, which, unlike their adult counterparts, express high levels of p75 NTR , were killed by bathing the cultures with oligomeric A␤ 1-42 peptides, but were unaffected by A␤ [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] peptides. This finding is in agreement with many other studies showing that the carboxyl amino acids of the amyloid peptide are important for neuronal toxicity (Klein et al., 2004; Costantini et al., 2005) , and supports the more recent idea that the soluble oligomeric protofibril form of A␤ 1-42 mediates amyloid neurotoxicity (Dahlgren et al., 2002; Gandy, 2005) . Moreover, we demonstrated that A␤ 1-42 -mediated neurotoxicity is abolished in the absence of p75 NTR expression. This confirms the involvement of p75 NTR -mediated signaling pathways in neuronal death reported in previous studies using nonprimary cell cultures treated with amyloid peptides (Coulson, 2006) .
We found that A␤-mediated death signaling resulted in, and required, increased production of the p75 NTR C-terminal fragment. It has been demonstrated that A␤ binds to the extracellular domain of p75 NTR (Yaar et al., 1997) , and that p75 NTR mediates death signaling in hippocampal neurons after neurotrophin application (Troy et al., 2002) . We found that an antibody to the p75 NTR extracellular domain had a significant effect on A␤ 1-42 -induced death. It is therefore possible that the interaction of A␤ 1-42 with p75 NTR promotes extracellular cleavage, such as occurs in response to other p75 NTR ligands (Kenchappa et al., 2006; Podlesniy et al., 2006; Coulson et al., 2008) . Although it is also a possibility that the antibody was preventing the binding and activation of p75 NTR by endogenously produced neurotrophins (Troy et al., 2002; Volosin et al., 2006) , the fact that ␥-secretase inhibitor treatment failed to promote cell death in the absence of A␤ suggests that additional A␤ 1-42 effects may play a role in the promotion of cell death.
Our experiments using HEK293 cells indicate that inhibition of ␥-secretase activity is a significant factor in promoting the accumulation of the C-terminal fragment. Although the exact mechanism by which this occurs is not known, our finding that APP processing is also affected by A␤, together with the demonstration that increased expression of the APP C-terminal frag- NTR before overnight treatment with A␤ 1-42 and/or 3 h treatment with PMA and/or compound E (CpdE). All cultures were treated with ␤-clasto-lactacystin. D, Western blot of p75 NTR C-terminal fragment mimic ⌬⌭14 in lysates of transfected HEK293 cells after overnight treatment with A␤ 1-42 or 3 h treatment with CpdE or PMA. E, F, Luciferase activity in lysates of HEK293 cells coexpressing ⌬⌭14-Gal4 (E) or C99-Gal4 (F ) together with pUAS (black bars) after treatment with A␤ 1-16 , A␤ 1-42 , or CpdE. Gray bars indicate positive-control (pCMV-Gal-and pUAS-transfected cells) and negative-control (cells transfected with pUAS alone) conditions. The total amount of total protein in lysates (white bars; in micrograms per microliter) is also shown in E (n ϭ 6 samples from 2 experiments). *p Ͻ 0.05; **p Ͻ 0.01; ***p Ͻ 0.001. n ϭ 4 experiments for all other conditions. ment has a similar effect on p75 NTR processing, suggests that A␤ 1-42 could act as a competitive ␥-secretase substrate. This mode of action, in agreement with our finding that ␥-secretase inhibitor treatment promoted rather than inhibited A␤-induced neuronal death, would preclude A␤-induced cell death being mediated via the intracellular domain pathway described by others (Kenchappa et al., 2006; Podlesniy et al., 2006) . However, we have previously shown that the C-terminal fragment of p75 NTR is constitutively active in signaling neuronal death, and have recently defined a signaling cascade by which it results in caspase activity (Coulson et al., 2000 Underwood et al., 2008) .
In support of p75 NTR playing a key role in A␤ 1-42 -induced neurodegeneration, we found that injection of A␤ 1-42 into the hippocampus of wild-type mice, a model of Alzheimer's disease, resulted in the degeneration of ChAT-positive forebrain neurons in vivo. Although our analysis did not specifically determine that ChAT-positive cells had died after A␤ 1-42 exposure at axonal terminals, it did demonstrate the loss of cellular neurotransmitter production and hence loss of function of these neurons. It has also been shown in aged animals that ChAT downregulation correlates with loss of hippocampal function (Yeo et al., 1997) and that this precedes the death of basal forebrain neurons (Greferath et al., 2000) .
This functional loss of cholinergic forebrain neurons in vivo was also prevented by p75 NTR deficiency, supporting the hypothesis that p75
NTR -mediated degeneration of basal forebrain neurons is an early consequence of increased oligomeric A␤ levels and is tightly linked to the loss of septohippocampal function observed in both animal models and human patients with Alzheimer's disease (Klein et al., 2004; Gimenez-Llort et al., 2007) . Although a significant difference in the numbers of ChAT-positive basal forebrain neurons correlated directly with A␤ 1-42 exposure, we found no obvious difference in the amount of damage in the hippocampus after injections into the CA1 region, regardless of A␤ peptide length or genotype. In the adult hippocampus, unlike the embryonic hippocampus and the adult basal forebrain, p75
NTR is downregulated, although it can be upregulated in response to injury (Dechant and Barde, 2002) . This observation further highlights the connection between the degeneration of neurons that express high levels of p75 NTR and A␤ 1-42 peptide exposure. Although our in vitro results demonstrate that A␤ 1-42 -induced, p75
NTR -mediated neuronal death is likely to result from inhibition of ␥-secretase activity, other injuryinduced factors, such as modulation of synaptic plasticity (Klein et al., 2004) , and/or neurotrophins released by reactive astrocytes (Pehar et al., 2004) , could also contribute to, and indeed may be required to, promote cell death in vivo via a p75 NTRdependent mechanism.
In conclusion, we have shown that A␤ 1-42-induced neuronal degeneration of embryonic hippocampal neurons in vitro and basal forebrain neurons in vivo requires p75 NTR . Furthermore, the activation of neuronal loss strongly correlates with increased accumulation of the constitutively active death-signaling C-terminal fragment of p75 NTR generated by inhibition of ␥-secretase activity. Although p75 NTR has been causally linked to the progression of Alzheimer's disease for over a decade, the current results provide a novel mechanism to explain the early and characteristic degeneration of the septohippocampal pathway that occurs in this disease.
